Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes

The level of transduction efficiency of the target retinal cells affects the choice of AAV serotype and the outcome of gene replacement therapy for inherited retinal diseases. This study focused on the tropism and transduction efficiency of AAV2.7m8-, AAV5-, AAV8-, and AAV9-GFP in ARPE-19 and HEK293...

Full description

Bibliographic Details
Main Authors: Dzerassa Gurtsieva, Ekaterina Minskaia, Sofia Zhuravleva, Elena Subcheva, Elena Sakhibgaraeva, Andrew Brovin, Artem Tumaev, Alexander Karabelsky
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/1/138
_version_ 1797342703464218624
author Dzerassa Gurtsieva
Ekaterina Minskaia
Sofia Zhuravleva
Elena Subcheva
Elena Sakhibgaraeva
Andrew Brovin
Artem Tumaev
Alexander Karabelsky
author_facet Dzerassa Gurtsieva
Ekaterina Minskaia
Sofia Zhuravleva
Elena Subcheva
Elena Sakhibgaraeva
Andrew Brovin
Artem Tumaev
Alexander Karabelsky
author_sort Dzerassa Gurtsieva
collection DOAJ
description The level of transduction efficiency of the target retinal cells affects the choice of AAV serotype and the outcome of gene replacement therapy for inherited retinal diseases. This study focused on the tropism and transduction efficiency of AAV2.7m8-, AAV5-, AAV8-, and AAV9-GFP in ARPE-19 and HEK293 cells. Fluorescence intensity was assessed bi-hourly by means of IncuCyte S3 live imaging microscopy. Within 12 h, AAV2.7m8 demonstrated the highest transduction efficiency at four viral concentrations of 1-, 3-, 6-, and 8 × 10<sup>4</sup> VG/cell in a dose-dependent manner, followed by AAV5 in ARPE-19 and AAV9 in HEK293 cells. The transduction efficiency of AAV2.7m8 at a dose of 6 × 10<sup>4</sup> VG/cell was 21, 202, and 323 times higher in ARPE-19 cells and 324, 100, and 52 times higher in HEK293 cells compared to AAV5, AAV8, and AAV9, respectively. This trend remained for 4 days at all viral concentrations, as additionally shown by flow cytometry. At a dose of 6 × 10<sup>4</sup> VG/cell, AAV2.7m8 (97% GFP-positive cells, GFP +) was nearly two and 10 times as efficient as AAV5 (52% GFP+) and AAV9 or AAV8 (both 9%), respectively, in ARPE-19 cells. In HEK293 cells, 95% of AAV2.7m8-, 26% of AAV9-, 17% of AAV8-, and 12% of AAV5-transduced cells were GFP-positive.
first_indexed 2024-03-08T10:37:08Z
format Article
id doaj.art-1c42311fcf654b39b5d703fc771d0224
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-08T10:37:08Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-1c42311fcf654b39b5d703fc771d02242024-01-26T18:08:21ZengMDPI AGPharmaceutics1999-49232024-01-0116113810.3390/pharmaceutics16010138Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 SerotypesDzerassa Gurtsieva0Ekaterina Minskaia1Sofia Zhuravleva2Elena Subcheva3Elena Sakhibgaraeva4Andrew Brovin5Artem Tumaev6Alexander Karabelsky7Department of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaDepartment of Gene Therapy, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, RussiaThe level of transduction efficiency of the target retinal cells affects the choice of AAV serotype and the outcome of gene replacement therapy for inherited retinal diseases. This study focused on the tropism and transduction efficiency of AAV2.7m8-, AAV5-, AAV8-, and AAV9-GFP in ARPE-19 and HEK293 cells. Fluorescence intensity was assessed bi-hourly by means of IncuCyte S3 live imaging microscopy. Within 12 h, AAV2.7m8 demonstrated the highest transduction efficiency at four viral concentrations of 1-, 3-, 6-, and 8 × 10<sup>4</sup> VG/cell in a dose-dependent manner, followed by AAV5 in ARPE-19 and AAV9 in HEK293 cells. The transduction efficiency of AAV2.7m8 at a dose of 6 × 10<sup>4</sup> VG/cell was 21, 202, and 323 times higher in ARPE-19 cells and 324, 100, and 52 times higher in HEK293 cells compared to AAV5, AAV8, and AAV9, respectively. This trend remained for 4 days at all viral concentrations, as additionally shown by flow cytometry. At a dose of 6 × 10<sup>4</sup> VG/cell, AAV2.7m8 (97% GFP-positive cells, GFP +) was nearly two and 10 times as efficient as AAV5 (52% GFP+) and AAV9 or AAV8 (both 9%), respectively, in ARPE-19 cells. In HEK293 cells, 95% of AAV2.7m8-, 26% of AAV9-, 17% of AAV8-, and 12% of AAV5-transduced cells were GFP-positive.https://www.mdpi.com/1999-4923/16/1/138IRDretinopathygene therapyAAV serotypesAAV tropismretina
spellingShingle Dzerassa Gurtsieva
Ekaterina Minskaia
Sofia Zhuravleva
Elena Subcheva
Elena Sakhibgaraeva
Andrew Brovin
Artem Tumaev
Alexander Karabelsky
Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
Pharmaceutics
IRD
retinopathy
gene therapy
AAV serotypes
AAV tropism
retina
title Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
title_full Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
title_fullStr Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
title_full_unstemmed Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
title_short Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
title_sort engineered aav2 7m8 serotype shows significantly higher transduction efficiency of arpe 19 and hek293 cell lines compared to aav5 aav8 and aav9 serotypes
topic IRD
retinopathy
gene therapy
AAV serotypes
AAV tropism
retina
url https://www.mdpi.com/1999-4923/16/1/138
work_keys_str_mv AT dzerassagurtsieva engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT ekaterinaminskaia engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT sofiazhuravleva engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT elenasubcheva engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT elenasakhibgaraeva engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT andrewbrovin engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT artemtumaev engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes
AT alexanderkarabelsky engineeredaav27m8serotypeshowssignificantlyhighertransductionefficiencyofarpe19andhek293celllinescomparedtoaav5aav8andaav9serotypes